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ABSTRACT
Episodes of adult bacterial meningitis (ABM) at a Danish hospital in 1991–2000 were identified from the
databases of the Department of Clinical Microbiology, and compared with data from the Danish
National Patient Register and the Danish National Notification System. Reduced penicillin susceptibility
occurred in 21 (23%) of 92 cases of known aetiology, compared to an estimated 6% in nationally notified
cases (p < 0.001). Ceftriaxone plus penicillin as empirical treatment was appropriate in 97% of ABM
cases in the study population, and in 99.6% of nationally notified cases. The notification rate was 75%
for penicillin-susceptible episodes, and 24% for penicillin-non-susceptible episodes (p < 0.001). Cases
involving staphylococci, Pseudomonas spp. and Enterobacteriaceae were under-reported. Among
51 ABM cases with no identified risk factors, nine of 11 cases with penicillin-non-susceptible bacteria
were community-acquired. Severe sequelae correlated independently with age, penicillin non-suscep-
tibility, mechanical ventilation and non-transferral to a tertiary hospital (p < 0.05; logistic regression).
Other factors that correlated with severe sequelae by univariate analysis only were inappropriate clinical
handling, abnormal consciousness, convulsions and nosocomial infection. Overall, the data indicated
that neither age alone, community-acquired infection nor absence of identified risk factors can predict
susceptibility to penicillin accurately. Recommendations for empirical antibiotic treatment for ABM
should not be based exclusively on clinical notification systems with possible unbalanced under-
reporting.
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INTRODUCTION
Despite the availability of effective antibiotics,
adult bacterial meningitis (ABM) still has severe
sequelae and is fatal in 10–50% of patients,
depending on the bacterial aetiology [1–4]. The
optimal empirical antibiotic regimens are seldom
tested in randomised studies, but are usually
based on surveillance data. The incidence of
penicillin-non-susceptible (PNS) isolates in several
northern European countries is < 5% for invasive
pneumococci, < 15% for Haemophilus influenzae,
and < 1% for meningococci (http://www.earss.
rivm.nl) [5, 6], while penicillin-susceptible bacteria
account for c. 95% of ABM cases according to
surveillance data [7, 8]. Discussion has therefore
continued as to whether penicillin is an optimal
empirical antibiotic regimen for adult meningitis
in patients aged < 50 or 60 years with no special
risk factors [7–9]. In such cases, penicillin alone is
recommended in The Netherlands [7, 9], while a
third-generation cephalosporin is preferred in the
UK [8]. The only existing official guideline in
Denmark currently recommends penicillin for all
adults, irrespective of age, supplemented with
ceftriaxone according to clinical judgement [10].
No specific treatment advice with regard to risk
factors, suspected primary focus of infection or
nosocomial meningitis is given [10].
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A survey in 1990 demonstrated the absence of
consensus in Denmark regarding empirical anti-
biotic regimens for community-acquired ABM,
and indicated that either a penicillin alone, or a
third-generation cephalosporin plus a penicillin,
was recommended by departments of clinical
microbiology and infectious diseases [11]. A
follow-up survey in 2001 of 87 departments of
internal medicine, infectious diseases and clinical
microbiology in Denmark, with a 95% reply rate,
demonstrated an equal division between the same
two alternatives for empirical treatment [12]. As a
substantial number of cases of ABM appear not to
be reported to the compulsory National Notifica-
tion System for Infectious Diseases, the true
proportion of bacteria with susceptibility to peni-
cillin, on which the recommendations are based,
remains uncertain.
The aim of this study was to identify all cases
of ABM admitted to a Danish county hospital
during the period 1991–2000, focusing on the
aetiology, susceptibility to penicillin, and rela-
tionship between risk factors, prognostic factors
and outcome, and to assess the expected efficacy
of the UK, Dutch and Danish recommendations
regarding empirical antibiotic treatment. The
following hypotheses were tested: (1) that the
aetiological distribution and incidence of peni-
cillin susceptibility in the study population did
not differ from that of nationally notified cases
of ABM; (2) that the two empirical antibiotic
regimens recommended locally would both be
effective in > 95% of the cases in the study
population; (3) that the prevalence of predispo-
sing factors and prognostic factors might differ
between patients infected with penicillin-sus-
ceptible bacteria and those infected with PNS
bacteria.
MATERIALS AND METHODS
Study population
This comprised adult patients (aged > 14 years) with bacterial
meningitis admitted to Copenhagen County Hospital of
Gentofte (a suburban university hospital admitting all
patients from a Danish community with 124 470 adult
inhabitants) during the period 1991–2000. Neurosurgery
was not performed in the hospital, apart from surgery for
acoustic schwannomas in the Department of Oto-Rhino-
Laryngology (21–39 patients ⁄ year). The indication for referral
to the department of infectious diseases at a tertiary hospital
was not standardised during the study period. The age-
group proportions in 1995 in Denmark overall (n = 5 215 718)
and in the Gentofte Hospital admittance area (n = 146 911),
respectively, were: 0–14 years, 17.3% and 15.3%; 15–30 years,
22.9% and 17.9%; 31–40 years, 14.6% and 14.0%; 41–
50 years, 15.0% and 15.6%; 51–60 years, 11.3% and 11.6%;
61–70 years, 8.8% and 10.4%; > 70 years, 10.2% and 15.3%
(http://www.dst.dk). A difference in proportions of > 0.3%
was statistically significant.
Case definition of bacterial meningitis
In patients with a clinical picture of meningitis, verified bacterial
aetiology was defined as:
1. positive Gram stain or culture-positive cerebrospinal fluid
(CSF), or
2. negative Gram stain and culture-negative CSF, with posit-
ive blood culture and biochemical findings in CSF compat-
ible with bacterial meningitis not induced by other diseases
such as haemorrhage, infarct, or blood admixture (neutro-
phil pleocytosis > 10 · 106 ⁄L and protein concentration
> 0.6 g ⁄L, or a glucose ratio < 0.4).
Non-repeated culture of apathogenic bacteria without
compatible biochemical changes in CSF was not regarded as
significant.
Probable but not verified bacterial meningitis (unknown
aetiology) was defined as:
1. negative Gram stain and culture-negative CSF and blood,
but biochemical findings in CSF compatible with bacterial
meningitis not induced by other diseases (haemorrhage,
infarct, blood admixture), or
2. when CSF was not available, if the clinical presentation and
course of disease were judged as bacterial meningitis and
the patient was treated as such.
The latter two groups were identified, but were not
included in further analyses. Cases of tuberculous meningitis,
mycotic meningitis and neuroborreliosis were excluded. Com-
munity-acquired (as opposed to nosocomial) meningitis was
categorised according to Centers for Disease Control defini-
tions [13], and was based on the timing of central nervous
system symptoms in relation to admission and recent dis-
charge, and on the absence of central nervous system shunts
and catheters.
Data sources
1. Department of Clinical Microbiology of Copenhagen
County, Herlev Hospital, Denmark, which receives all
microbiological samples from Gentofte Hospital: cases
with a positive Gram stain or culture-positive CSF in the
ADBakt database (Autonik, Sko¨ldinge, Sweden). In addi-
tion, all cases with negative microbiological results, but
with polymorphonuclear leukocytosis in CSF, were re-
viewed for possible bacterial meningitis in the medical
records.
2. Department of Internal Medicine F, Gentofte Hospital,
Denmark: cases with a discharge diagnosis of bacterial
meningitis.
3. The National Notification System for Infectious Diseases,
Department of Epidemiology, Statens Serum Institut (SSI
data), Copenhagen, Denmark: notified cases of bacterial
meningitis with a clinical diagnosis of bacterial meningitis
or identified bacteria in CSF. Notification is compulsory,
independent of whether infection was nosocomial or
community-acquired.
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4. Departments of Medical Officers of Health for Copenhagen
Municipality and County: cases with bacterial meningitis
notified by telephone or in writing, and admitted to
Gentofte Hospital, with no differentiation between commu-
nity-acquired and nosocomial infection.
5. The National Patient Register: cases with a discharge
diagnosis of bacterial meningitis admitted to Gentofte
Hospital in 1991–2000.
Definitions
Empirical antibiotic treatment of adult bacterial meningitis
This was defined as the initial therapy prescribed by the
Department of Internal Medicine at Gentofte Hospital before
the aetiology was indicated or identified by Gram stain or
culture. From 1991 to 1995, this comprised intravenous
penicillin 15–20 million U ⁄day or ampicillin 12 g ⁄day, as
recommended during the entire study period on a national
basis. From 1996, intravenous penicillin or ampicillin was
prescribed in the doses indicated above plus ceftriaxone
4 g ⁄day, as recommended by the local department of internal
medicine and the regional tertiary hospital departments of
infectious diseases and clinical microbiology. The presence of
nosocomial infection, identified risk factors or immunosup-
pression necessitated relevant broad-spectrum antibiotic ther-
apy, but this was not specified in the local or national
recommendations.
Antibiotic susceptibility testing
Criteria for determining reduced susceptibility to penicillin
were those of the Swedish Reference Group for Antibiotics
(SRGA; http://www.ltkronoberg.se/ext/raf/artmic2.htm).
Antibiotic susceptibility testing was performed with AB
Biodisks (Solna, Sweden) on PDM II sensitivity medium, with
blood supplementation if relevant. The breakpoints used were
generally according to the recommendations of the SRGA then
in force. For penicillin G, these were: susceptible (S),
MIC £ 2 mg ⁄L; intermediately susceptible (I) or resistant (R)
(= PNS), MIC > 2 mg ⁄L. Species-specific breakpoints for Strep-
tococcus pneumoniae were: S, MIC £ 0.094 mg ⁄L; I, MIC 0.094 to
< 2 mg ⁄L; R, MIC ‡ 2 mg ⁄L.
Data on antibiotic susceptibility were not available in the
National Notification System of Infectious Diseases, but were
expected to be similar to published data for bacteraemia [14].
Therefore, all enteric Gram-negative bacilli, all Staphylococcus
epidermidis, 90% of Staphylococcus aureus, 15% of H. influenzae
and 2% of S. pneumoniae causing ABM were assumed to have
reduced susceptibility to penicillin in the SSI data.
Primary meningitis was defined as a case with no verified
primary focus of infection following clinical, microbiological
and radiological tests.
Data analysis
Clinical data for ABM patients identified in the medical
records included: the pre-admittance course and antibiotic
treatment; time-points of admittance, lumbar puncture and
empirical antibiotic treatment; risk factors as defined below;
symptoms; clinical observations; final antibiotic therapy and
supplementary treatment; microbiological findings, penicillin
susceptibility and advice given by the doctors from the
Department of Clinical Microbiology; biochemical findings;
and sequelae. Risk factors included alcohol misuse, liver
cirrhosis, diabetes mellitus, splenectomy, malignancy, severe
rheumatological disease, primary or secondary immunosup-
pression, recent head trauma (within 2 months), hydroceph-
alus with CSF shunt, previous meningitis, or surgery for
acoustic schwannoma. Severe sequelae included bilateral
anacusis, comprehensive vestibular, neurological or cognitive
deficits, amputation of extremities, and death. Mild sequelae
included moderate hearing loss, mild tinnitus, slight vestibu-
lar, neurological or cognitive deficits, and peripheral joint
amputation of fingers or toes.
Any delays in diagnosis or in administration of empirical
antibiotic treatment were noted on the basis of times of
admittance, CSF and blood sampling, and intravenous antibi-
otic administration, all of which were documented accurately.
Time-points of the accompanying symptoms and clinical
findings were documented less accurately. From the symp-
toms and clinical findings described in the medical records, the
diagnosis of bacterial meningitis at the time of admittance to
the hospital was assessed as obvious, possible, or not to be
expected. Accordingly, the clinical handling of each patient
admitted to hospital was defined as appropriate if the delay in
diagnosis was £ 4 h, the delay in administration of empirical
antibiotic treatment was £ 2 h, and a regimen of empirical
antibiotics, as defined above, was given initially at ‡ 0.5 · the
recommended dosage for cases of suspected bacterial menin-
gitis. Inappropriate handling was defined as a delay in diagno-
sis of > 4 h, or a delay in administration of empirical antibiotic
treatment of > 2 h, or empirical antibiotic treatment that
differed from the recommendations above, or an initial dosage
< 0.5 · the recommended dosage for cases of suspected
bacterial meningitis.
Clinical microbiological advice, as recorded in the patient chart
and in the ADBakt data base, was defined as appropriate if any
deviations from departmental guidelines and recommenda-
tions were considered of minor importance. Inappropriate
advice was recorded when one of the following was advised:
penicillin alone for nosocomial meningitis, for immunodefi-
cient patients, or for patients who had recently visited
(< 3 days) countries with a high prevalence of PNS pneumo-
cocci; ampicillin as monotherapy for Gram-negative bacteria
before susceptibility results were known; single-antibiotic
therapy (including ceftriaxone alone) for Pseudomonas spp.;
an antibiotic dose of < 0.5 · the recommended dose; and if
immediate microscopy was not advised despite a clinical
suspicion of meningitis, as these major deviations from
recommendations could contribute to an unfavourable out-
come.
Statistics
Non-parametric analysis with chi-square test with likelihood
ratio, Yates’s correction or Fisher’s exact test was used for
categorical data and proportions. The Mann–Whitney U-test
and the Kruskal–Wallis test were used for continuous data.
Logistic regression modelling was performed for outcome
data. The expected probable correlations were decided before-
hand, and corrections for multiple testing were not performed
on these grounds. Epi-Info software v. 6.04b (WHO, Geneva,
Switzerland) and SPSS software v. 6.1.2. (SPSS Inc., Chicago,
IL, USA) were used. The level of statistical significance was
defined as p < 0.05.
The study was approved by the Danish Register Authorities
(j. no. 2001-41-1017; Datatilsynet, Copenhagen, Denmark).
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RESULTS
In total, 130 patients with verified or probable
ABM were admitted, with 92 cases of verified
bacterial aetiology (Table 1) and 38 (29%) cases of
unknown aetiology. Mortality was 25% for all
cases and 32% for verified cases. Further analyses
were done on verified ABM cases only. Fifty-eight
(63%) of the verified ABM cases were reported,
but notification rates were lower for cases invol-
ving Staph. aureus or enteric Gram-negative bac-
teria (Table 1). The notification rate was 72%
(58 ⁄ 81) for community-acquired meningitis cases
vs. 0 ⁄ 11 for nosocomial cases. The overall notifi-
cation rates did not change between age groups or
with time, apart from a difference in notification
rates seen for S. pneumoniae between the first and
second 5-year periods (35% and 92%, respect-
ively), coinciding with the implementation of
active surveillance for this species. Active sur-
veillance for Neisseria meningitidis was on-going
during the entire study period.
A comparison between the study population
and all cases of ABM notified nationally (SSI data)
demonstrated a significant difference in the
microbiological distribution (p < 0.001), with rel-
atively fewer cases of N. meningitidis (16% vs.
54%) and more cases of Staph. aureus (12% vs.
3%) and Escherichia coli (5% vs. 0.8%) in the study
population (Table 1). The median age was higher
in the study population (69 vs. 50 years;
p < 0.001; Fig. 1A), and the male:female ratio
was lower (0.50 vs. 0.99; p < 0.05), compared to
the SSI data. According to the criteria in the case
definition, the diagnostic contributions to ABM in
the study population are presented in Table 2.
One patient had a CSF sample with 1456 leuko-
cytes that contained Gram-negative diplococci
with no positive cultures, but with cutanous
petecchiae. This patient was included as an
N. meningitidis case with predictable susceptibility
to penicillin.
Twenty-one of the 92 cases in the study pop-
ulation had reduced susceptibility to penicillin
(23%; 95% CI 15–33), comprising ten Staph. aureus
(10 ⁄ 11 Staph. aureus), eight Enterobacteriaceae
(8 ⁄ 8), one H. influenzae (1 ⁄ 3), one Staph. epidermidis
(1 ⁄ 1), and one S. pneumoniae (1 ⁄ 40) (Table 3). Ten
of these 21 patients received adequate initial
antibiotic treatment according to post-hoc evalu-
ation. A primary focus was identified in 14 of
these 21 cases, although with a considerable time
lapse between the diagnosis of meningitis and
identification of the primary focus (range 0–72 h).
The proportion of bacterial isolates with reduced
penicillin susceptibility among the cases of ABM
notified nationally (SSI data), as estimated from
regional bacteraemia data, was 6% (86 ⁄ 1437) of
cases (Table 3), compared with 23% (21 ⁄ 92) in the
study population (p < 0.001). The PNS bacteria
were not found among patients in the study
population aged < 30 years (n = 34), but the pro-
portion of these bacteria was higher in all other
age groups compared to the SSI data population.
This was also found with the community-
acquired cases only (Fig. 1B). These differences
were statistically significant by subgroup analysis
in the three groups aged > 50 years (p < 0.05).
Reduced susceptibility to penicillin occurred in
13 (16%) of the 81 community-acquired cases in
the study population, compared to eight (73%) of
the 11 episodes among the nosocomial cases
Table 1. Distribution of pathogens
in patients with verified adult bac-
terial meningitis 1991–2000
Gentofte Hospital SSI dataa
Fatal
cases
Notified
cases
Community-
acquired Nosocomial
All
cases (%)
All
(notified)
cases (%) p
Streptococcus pneumoniae 12 29 40 – 40 (43) 597 (42) 0.72
Neisseria meningitidis – 15 15 – 15 (16) 643 (54) < 0.001
Listeria monocytogenes 2 5 7 – 7 (8) 53 (4) 0.09
Staphylococcus aureus 6 3 8 3 11 (12) 44 (3) < 0.001
Haemolytic streptococci 3 3 4 2 6 (7) 38 (3) 0.04
Haemophilus influenzae 2 2 3 – 3 (3) 34 (2) 0.48
Escherichia coli 2 – 3 2 5 (5) 12 (0.8) 0.002
Pseudomonas spp. 2 – – 2 2 (2) 3 (0.2)
Staphylococcus epidermidis – – – 1 1 (1.1) 0
Capnocytophaga canimorsus – 1 1 – 1 (1.1) 4 (0.3)
Enterobacter cloacae – – – 1 1 (1.1) 1 (0.1)
Others, known 8 (0.6) 1.0
Total no. 29 (32%) 58 (63%) 81 11 92 (100) 1437 (100)
aNational Notification System for Infectious Diseases.
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(p < 0.001). The 13 community-acquired cases
included eight Staph. aureus, three E. coli, one
H. influenzae and one S. pneumoniae, and nine of
these 13 patients had no risk factors. Among the
51 cases of ABM without risk factors, 11 patients
(age range 33–93 years) were infected with PNS
bacteria. Most (9 ⁄ 11) of these cases were commu-
nity-acquired infections, with one patient aged
< 50 years.
Staph. aureus accounted for almost half of the
PNS cases and deserves special attention. The
mortality rate among cases of Staph. aureus men-
ingitis was 55%, and no sequelae resulted among
the survivors. Eight of the 11 Staph. aureus cases
were community-acquired infections, and five of
these eight patients had no risk factors (age range,
60–84 years). Three patients had no identified
primary focus if bacteraemia was excluded. No-
socomial meningitis was secondary to neurosur-
gery (one case), post-operative subcutaneous
wound infection (one case), and the presence of
a central nervous system shunt (one case). Other
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Fig. 1. (a) Age distribution for cases of verified adult bacterial meningitis (ABM) at Gentofte Hospital (n = 92) compared to
nationally notified cases (SSI data, n = 1437), 1991–2000. (b) Percentage of penicillin non-susceptibility in ABM patients
according to age group in SSI data, and at Gentofte Hospital for all cases and for community-acquired cases only, 1991–
2000.
Table 2. Diagnostic indications for 92 cases of verified
adult meningitis at Gentofte Hospital during 1991–2000
CSF positive
by
Gram stain
Culture-
positive
CSF
Culture-
positive
blood
Biochemistry-
positive
CSF
Total 55 (60%) 75 (82%) 73 (79%) 78 (85%)
Single
diagnostic result
1 (1%) 9 (10%) 10 (11%) 0
Missing
data
1 (1%) 1 (1%) 1 (1%) 6 (6%)
Table 3. Distribution of pathogens
according to penicillin susceptibility
among patients with verified adult
bacterial meningitis during 1991–
2000
Gentofte Hospital SSI dataa
Penicillin
non-susceptible
n = 21
Penicillin
susceptible
n = 71
Penicillin
non-susceptible
n = 86
Penicillin
susceptible
n = 1351
Streptococcus pneumoniae 1b 39 15 582
Neisseria meningitidis 0 15 0 643
Listeria monocytogenes 0 7 0 53
Staphylococcus aureus 10 1 42 2
Haemolytic streptococci 0 6 0 38
Haemophilus influenzae 1 2 5 29
Escherichia coli 5 0 12 0
Pseudomonas spp. 2 0 3 0
Staphylococcus epidermidis 1 0
Klebsiella spp. 3 0
Capnocytophaga canimorsus 0 1 0 4
Salmonella spp. 1 0
Enterobacter cloacae 1 0 1 0
Proteus vulgaris 1 0
Enterococci 1 0
Anaerobes, unspecified 2 0
Notified 5 53 86 1351
aEstimated from regional bacteraemia data.
bIntermediate susceptibility (MIC 0.125–1 mg ⁄L).
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primary infectious foci were identified later dur-
ing the illness in one patient with endocarditis,
two patients with septic arthritis, one patient with
osteomyelitis, and one patient with a subcuta-
neous abscess. Although all cases except the post-
neurosurgical patient had positive blood cultures,
the tentative diagnosis of septicaemia or menin-
gitis was not made initially. Instead, the tentative
diagnoses on hospital admittance included back
pain, myocardial infarction, pneumonia, influ-
enza, intoxication, hydrocephalus and liquorrhea.
The Danish national recommendation of initial
empirical treatment of ABM with penicillin
monotherapy was assessed as adequate according
to the susceptibility results in 77% (71 ⁄ 92) of the
cases in the study population, and in 94%
(1351 ⁄ 1437) of the cases in the SSI data (Table 3).
Excluding the patients with risk factors, nosoco-
mial infection or aged > 60 years (by analogy with
the Dutch recommendations [7]), 88% (15 ⁄ 17)
would be treated adequately with penicillin
monotherapy. If the UK recommendation of
ceftriaxone or cefotaxime was used [8], possibly
implying that listeriosis occurs seldom in patients
aged 18–50 years without risk factors, the patients
in the study population were all (20 ⁄ 20) treated
appropriately.
An alternative antibiotic regimen used widely
in Denmark for ABM [12], consisting of a peni-
cillin plus ceftriaxone, was adequate for 97% of
the episodes (89 ⁄ 92) in the study population, and
in 100% of community-acquired cases (n = 81).
Two cases caused by Pseudomonas spp. and one
caused by a methicillin-resistant Staph. aureus
strain among the nosocomial cases would not be
covered initially by this latter antibiotic regimen,
which would be expected to be adequate in 99.6%
(1430 ⁄ 1437) of cases notified nationally (SSI data;
Table 3).
In the study population, the patient group with
ABM caused by bacteria with reduced penicillin
susceptibility had a higher rate of severe sequelae,
including death (62% vs. 30%; Table 4), and had
a lower rate of notification (24% vs. 75%;
Table 3), compared to patients with ABM caused
by penicillin-susceptible bacteria. With regard to
the prognostic factors (Table 4), a higher propor-
tion of patients with PNS bacteria had nosocomial
infection (38% vs. 4%), experienced deteriorating
consciousness during their hospital stay (57% vs.
31%), were handled in a clinically inappropriate
manner (52% vs. 25%), and were associated with
inappropriate advice from the Department of
Clinical Microbiology (24% vs. 3%). No statisti-
cally significant differences were demonstrated
between the two groups in terms of age, mortality
rate, prevalence of septic shock syndrome or
disseminated intravascular coagulation, or pre-
valence of any risk factors.
The possible association of prognostic factors
and relevant biochemical parameters with out-
come was analysed for all 92 episodes of ABM.
The outcome measure of severe sequelae (which
included death) was associated by univariate
analysis (p < 0.05) with older age, reduced
penicillin susceptibility, nosocomial infection,
inappropriate clinical handling, delay in admin-
istration of adequate antibiotic treatment, abnor-
mal mental state at admission, deteriorating
consciousness, convulsions, a higher proportion
of positive blood cultures, a higher level of
leukocytosis in CSF, a lower level of leukocytosis
in peripheral blood, a low haemoglobin concen-
tration, and failure to transfer the patient to a
tertiary hospital department of infectious disease.
In a logistic regression model, severe sequelae
were associated independently with age
(OR = 1.10; 95% CI 1.05–1.17; p < 0.001), mechan-
ical ventilation (OR = 7.9; 95% CI 1.8–33.9;
p < 0.01), reduced penicillin susceptibility
(OR = 6.5; 95% CI 1.4–30.9; p < 0.05), and transfer
Table 4. Outcome, prognostic factors and predisposing
factors among cases of verified adult bacterial meningitis
at Gentofte Hospital during 1991–2000
Known aetiology
Penicillin
non-susceptible
n = 21
Penicillin
susceptible
n = 71 p valuea
Total
n = 92
Outcome
Death 10 19 0.12 29
Sequelae, severe 13 21 0.01 34
Sequelae, total 14 37 0.35 51
Prognostic factors
Inappropriate handling 12 18 0.01 30
CMA, inappropriate 5 2 0.006 7
DIC 0 8 0.19 8
Septic shock syndrome 9 27 0.88 36
Mechanical ventilation 7 42 0.06 49
Reduced consciousness 16 61 0.32 77
Deteriorated consciousness 12 22 0.05 34
Convulsions < 24 h 1 16 0.11 17
Tertiary transferralb 7 37 0.20 44
Age, median (years) 72 68 0.09 –
Nosocomial meningitis 8 3 < 0.001 11
Predisposing factors
Risk factors, any 10 31 0.94 41
CMA, clinical microbiological advice; DIC, disseminated intravascular coagulation.
aUnivariate estimates (chi-squared test).
bTransferral to the Department of Infectious Diseases at a tertiary-level university
hospital.
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to a department of infectious diseases (OR = 0.21;
95% CI 0.06–0.80; p < 0.05).
DISCUSSION
Notification of bacterial meningitis in other coun-
tries has been described as incomplete [15, 16],
and at Gentofte Hospital, a notification rate of
only 63% for verified cases was demonstrated by
thorough case finding using all available data
sources. Registration bias concerning primary
diagnoses and notification was demonstrated in
the study population, as notification occurred in
only 24% of cases with reduced susceptibility to
penicillin and in none of the nosocomial cases.
Episodes with these aetiologies may also be
under-represented markedly among the notified
cases on a national level, and the extent of this
under-notification needs to be clarified further.
Jensen et al. [17] restrospectively described 104
Danish cases of Staph. aureus meningitis from 1986
to 1989, but only 14 cases were notified nationally
in the same period, confirming the very low
notification rates of certain bacteriological aetiol-
ogies if an active surveillance system is not
established. As neither the age-group-specific
rates of notification nor the median age of ABM
patients from other Danish hospitals were avail-
able, it is uncertain whether the noted deviation
towards older meningitis patients in the study
population is representative. Cases of purulent
meningitis where a bacterial aetiology could not
be demonstrated were excluded from further
analyses, as the clinical picture and biochemical
changes might have been caused by other events,
including viral infection or vascular-related epi-
sodes.
The aetiological distribution of ABM in a recent
Dutch national survey [7] implicated PNS bacteria
(staphylococci, enterococci, P. aeruginosa, E. coli)
in c. 10% of cases. The median age of the patients
was not stated, but an age-based classification
was used [7]. In the present study population, the
age distribution of the cases with reduced suscep-
tibility to penicillin was not statistically different
from that of the cases caused by penicillin-
susceptible bacteria. Compared to cases notified
nationally, the higher median age in the study
population may contribute to a different micro-
biological spectrum because of an association
with a higher prevalence of risk factors, immu-
no-incompetence and vulnerability to disease.
Despite age-group stratification, the proportion
of penicillin-susceptible bacteria differed between
the two populations. An unbalanced national
under-reporting of nosocomial cases could con-
tribute to this result. As no national data were
available regarding the prevalence of risk factors
in all notified ABM patients, the possible influ-
ence on the distribution of bacterial pathogens
and the related outcome could not be evaluated.
The male:female ratio decreased with advanced
age in both ABM populations, similar to the
official demographic data (http://www.dst.dk),
and the higher mean age of the study population
may thus explain the difference in gender ratio
between the two populations.
A substantial proportion of the identified bac-
teria in the study population were PNS, compared
with the estimated proportion from the SSI data.
A penicillin susceptibility rate of < 93% was also
found among the subgroups of community-
acquired cases aged 30–60 years with no risk
factors (as categorised in the Dutch recommenda-
tions). In practice, the presence of risk factors or a
primary focus in ABM may often be concealed at
the time of initial antibiotic treatment, but pre-
vious reports have not supplied data on the
frequency of this problem. With this background,
empirical penicillin monotherapy cannot be
recommended initially for the group aged
30–60 years (the Dutch and the Danish recom-
mendations), regardless of the absence of risk
factors. As the frequency of highly penicillin-
resistant pneumococci (MIC ‡ 2 mg ⁄L) is extre-
mely low in Denmark (none were found in the
present study), vancomycin still has no role in the
initial treatment of pneumococcal meningitis
before susceptibility results are available.
Bacterial meningitis results in a large propor-
tion of serious sequelae, and several authors have
considered the extent to which the prognosis is
changed by a moderate delay in diagnosis or by a
delay in administration of adequate treatment [1,
18–20]. No exact consensus is evident, as bacterial
meningitis is heterogeneous with regard to bac-
terial aetiology and virulence, rate of disease
progression, risk factors (such as impaired host
immunocompetence) and disease severity, but
treatment delay in relation to symptom progres-
sion is not expected to benefit patient outcome.
In the present study, with a relatively modest
number of ABM cases, age, reduced susceptibil-
ity to penicillin, mechanical ventilation and
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failure to transfer the patient to a tertiary hospital
each correlated independently with severe seque-
lae by multivariate model analysis. Correlation
with severe sequelae by univariate analysis was
demonstrated for several other parameters (delay
in initiation of antibiotic treatment, inappropriate
clinical handling in general, inappropriate micro-
biological advice, a low peripheral leukocyte
count, and a high CSF leukocyte count at the time
of lumbar puncture), all of which may be associ-
ated closely with the age parameter. This is in
accordance with the more non-specific symptoms
and clinical signs of ABM noted with greater age
[21, 22], and underscores the importance of a low
threshold of suspicion regarding bacterial menin-
gitis, especially among elderly patients. Other
factors related closely to the outcome measure
were not included in the logistic regression model,
but in accordance with earlier reports [1, 23],
decreased mental status at admission, deterior-
ating consciousness and the occurrence of convul-
sions were also associated with a poor outcome by
univariate analysis. The factor of transferral to a
tertiary hospital department of infectious diseases
was associated with a better outcome, but the
importance of this is uncertain because triage of
the patients did not follow standardised guide-
lines during the period, and may therefore conceal
confounding factors. The incidence of cases with
inappropriate clinical handling (33% overall) and
inappropriate microbiological advice (8% overall)
should not be neglected, and may indicate a need
for further case analyses and quality control of
clinical practice.
Possible factors that may influence the outcome
of ABM include early diagnosis based on a high
level of clinical attentiveness, compliance with
updated and evidence-based guidelines, and
swift and adequate antibiotic treatment based on
the expected susceptibility and appropriate clin-
ical microbiological advice. These factors may be
improved by on-going systematic quality control
and feedback. In many northern European coun-
tries, the prevalence of PNS S. pneumoniae isolates
is < 5%, while the prevalence of methicillin-
resistant Staph. aureus is < 1% in The Netherlands
and in Scandinavian countries (http://
www.earss.rivm.nl). Despite similar susceptibility
patterns, evident differences appear in the na-
tional guidelines for ABM. Future therapeutic
guidelines should not be based exclusively on the
bacterial distributions reported in compulsory
notification systems of infectious diseases, deliv-
ered overwhelmingly by clinicians, as unbalanced
under-reporting of certain bacteria seems to be
present. In contrast to (e.g.) the present Dutch
guidelines, penicillin monotherapy may not be
adequate as initial empirical antibiotic therapy for
patients aged 30–60 years, even when no risk
factors or co-morbidities are identified. As several
of the current national recommendations for ABM
may be based on partially incomplete data, there
is a further need to minimise unbalanced under-
reporting, possibly by supplementary active sur-
veillance with data from electronic laboratory
reporting.
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